NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Study on the Detection of Pleuropulmonary Manifestations in Rheumatoid Arthritis
Study on the Detection of Pleuropulmonary Manifestations in Rheumatoid Arthritis

NCT06965322

RecruitingN/A

Sponsor: Medical University Innsbruck

Conditions: Rheumatic Arthritis, Interstitial Lung Disease in Patients With Rheumatoid Arthritis

Countries: Austria

The aim of the study is to develop a standardized, risk-adapted screening protocol for detecting pleuropulmonary manifestations in patients with rheumatoid arthritis. To assess the risk of these manifestations, a comprehensive range of functional and clinical evaluations will be performed and correlated with structural lung assessments using computed tomography (CT).

Eligibility overview

Sex: ALL

Age: 18 Years to

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Patients ≥18 years diagnosed with rheumatoid arthritis according to current ACR/EULAR criteria
* Residence in Austria
* Signed and dated consent of the patient in accordance with ICH-GCP guidelines

Exclusion Criteria:

* pregnancy
* age below 18 years
* Contraindications to study-related routine examinations (e.g., inability to draw blood due to needle phobia, no CT scan possible due to claustrophobia, pregnancy, etc.)
Locations (1)
  • Innsbruck, Austria, Austria